Patent US4671797A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4671797A Expired / Lapsed US ⏱️ 0.0 years remaining

Heterologous arterial biograft and biological material treating process

Assignee: Individual
•
Filing: 1985-09-20
•
Granted: 1987-06-09
•
Expires: 2005-09-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention concerns a heterologous arterial biograft comprehending a heterologous biological material-made arterial duct, having its branches bound together (through micro technique) and keeping to a great extent its natural characteristics after submitted to a complete curing by a diabasic acid aldehyde aqueous balanced solution. The arterial duct shall preferably be a swine's or bovine's internal mammary artery.

Inventors

  • 👤 Mario O. Vrandecic Pedero

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 21:57
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3604; A61L27/3625; A61F; A61F2/00; A61F2/02; A61F2/04; A61F2/06; A61F2/062; A61K; A61K35/00; A61K35/12; A61K35/44; A61L27/3683; A61L27/3687; A61L27/50; A61L27/507

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 179 words
Biological material treating process, characterized by the taking of an animal artery, followed by the immediate binding (through micro technique) of every arterial branch; treatment of the bound duct to complete curing in a diabasic acid (to be selected out of succinic and glutaric acids--the glutaric acid to be preferred) aqueous aldehyde balanced solution that shall be kept within a concentration range extending from 0.001% to about 3% and including monomeric and polymeric free anhydride glutaric aldehydes having a monomer-polymer ratio of about 3:1 yet excluding unsaturated alpha-beta polymers, the solution to be tamponed with Mg group ions and having a pH above 7 and such an ionic power that the ions are kept in a range of about 250 Å to 300 Å, as spectrophotometrically proven; the solution to have an approximate 0.02% to 3% fixative to be selected out of the Periodic Table's group 8 metal ammoniacal oxychlorates (preferably Fe and Ru), at a temperature higher than 10° C. but less than the degradation temperature of the bath components until a histopathologically controlled satisfactory curing is obtained.
Claim 2
Dependent Claim 179 words
Biological material treating process, characterized by the taking of an animal artery, followed by the immediate binding (through micro technique) of every arterial branch; treatment of the bound duct to complete curing in a diabasic acid (to be selected out of succinic and glutaric acids--the glutaric acid to be preferred) aqueous aldehyde balanced solution that shall be kept within a concentration range extending from 0.001% to about 3% and including monomeric and polymeric free anhydride glutaric aldehydes having a monomer-polymer ratio of about 3:1 yet excluding unsaturated alpha-beta polymers, the solution to be tamponed with Mg group ions and having a pH above 7 and such an ionic power that the ions are kept in a range of about 250 Å to 300 Å, as spectrophotometrically proven; the solution to have an approximate 0.02% to 3% fixative to be selected out of the Periodic Table's group 8 metal ammoniacal oxychlorates (preferably Fe and Ru), at a temperature higher than 10° C. but less than the degradation temperature of the bath components until a histopathologically controlled satisfactory curing is obtained.
Claim 3
Dependent Claim 22 words
Biological material treating process, as claimed in claim 1, characterized by the fact that the animal artery is an internal mammary artery.
Claim 4
Dependent Claim 20 words
Biological material treating process, as claimed in claim 2, characterized by the fact that the internal mammary artery is swine's.
Claim 5
Dependent Claim 20 words
Biological material treating process, as claimed in claim 2, characterized by the fact that the internal mammary artery is bovine's.
Claim 6
Dependent Claim 59 words
A heterologous arterial biograft comprising an arterial duct made of heterologous biological material, said arterial duct having branches bound together and its integrity preserved so as to retain original elasticity within a 40% to 60% range and wall inner surface homogeneity within a 80% to 95% range, wherein the heterologous biological arterial duct is an animal internal mammary artery.
Claim 7
Dependent Claim 59 words
A heterologous arterial biograft comprising an arterial duct made of heterologous biological material, said arterial duct having branches bound together and its integrity preserved so as to retain original elasticity within a 40% to 60% range and wall inner surface homogeneity within a 80% to 95% range, wherein the heterologous biological arterial duct is an animal internal mammary artery.
Claim 8
Dependent Claim 18 words
A heterologous arterial biograft according to claim 5, wherein the internal mammary artery is a swine mammary artery.
Claim 9
Dependent Claim 18 words
A heterologous arterial biograft according to claim 5, wherein the internal mammary artery is a bovine mammary artery.

References Cited (Backward Citations)

US3570013A Cited
US3588920A Cited
US4098571A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-06-08 1990-12-08 1991-06-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-06-08 1994-12-08 1995-06-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-06-08 1998-12-08 1999-06-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag